<?xml version="1.0" encoding="utf-8"?><article>
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher">IJAR</journal-id>
			<journal-title>Indian Journal of Applied Research</journal-title>
			<issn pub-type="ppub">2249-555X</issn>
			<publisher>
				<publisher-name>Indian Society for Health and Advanced Research</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">ijar-8-3-14746</article-id>
			<article-categories>
				<subj-group>
					<subject>Original Research Paper</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>EARLY PREDICTION OF SIGNIFICANT HYPERBILIRUBINEMIA IN PRETERM NEONATES USING 24 HOURS SERUM BILIRUBIN- A PROSPECTIVE STUDY.</article-title>
			</title-group>
			<contrib-group><contrib contrib-type="author">
						<name>
							<surname>NEETHI</surname>
							<given-names>RAM</given-names>
							<prefix>Dr.</prefix>
						</name>
						<xref ref-type="aff" rid="aff000">
							<sup></sup>
						</xref>
						</contrib></contrib-group><pub-date pub-type="ppub">
				<month>March</month>
				<year>2018</year>
			</pub-date>
			<volume>8</volume>
			<issue>3</issue>
			<fpage>01</fpage>
			<lpage>02</lpage>
			<abstract>
				<title>ABSTRACT</title>
				<p><p>&nbsp;</p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%&quot;>Background: </span><span style=&quot;font&ndash;size:12.0pt;line&ndash;height:&#10;200%;font&ndash;weight:normal&quot;>Bilirubin induced neurological dysfunction is one of the major causes of morbidity in preterm neonates secondary to uncontrolled hyperbilirubinemia.<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;>While jaundice per se is not preventable none the less early detection of threatening bilirubin levels permit initiation of phototherapy and prevents kernicterus. <o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%&quot;>Objectives<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;><span style=&quot;mso&ndash;spacerun:yes&quot;>&nbsp; </span>To determine the first day total bilirubin value, at 24 hours of life; which will predict with reasonable accuracy,<span style=&quot;mso&ndash;spacerun:yes&quot;>&nbsp; </span>preterm neonates likely to develop subsequent significant hyperbilirubinemia requiring treatment.<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;>&nbsp;To establish the cut&ndash;off values and comparison of the obtained value for prediction of significant neonatal hyperbilirubinemia in preterm neonates.<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%&quot;>Material and methods<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;>The study was conducted on a group of<span style=&quot;mso&ndash;spacerun:yes&quot;>&nbsp; </span>90 preterm neonates, with no comorbidities,</span><span lang=&quot;RU&quot; style=&quot;font&ndash;size:12.0pt;line&ndash;height:200%;mso&ndash;ansi&ndash;language:RU;&#10;font&ndash;weight:normal&quot;><span style=&quot;mso&ndash;spacerun:yes&quot;>&nbsp; </span></span><span style=&quot;font&ndash;size:12.0pt;line&ndash;height:200%;font&ndash;weight:normal&quot;>over a period of one year. The main outcome measured was hyperbilirubinemia requiring intervention.<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span lang=&quot;IT&quot; style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;mso&ndash;ansi&ndash;language:IT;font&ndash;weight:normal&quot;>Serum bilirubin level was</span><span style=&quot;font&ndash;size:12.0pt;line&ndash;height:200%;font&ndash;weight:normal&quot;> sent at 24 hours of age. These babies were followed up clinically for the development of jaundice, and subsequent TSB values were obtained and assessed the need of phototherapy.<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;><o:p>&nbsp;</o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%&quot;><o:p>&nbsp;</o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%&quot;>Results<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;>Mean age at bilirubin estimation was 24 &plusmn; 2 hours with mean TSB of 6.03 &plusmn; 1.48 mg/dl. Significant hyperbilirubinemia was present in 60/90 babies (66.6%).Neonates belonging to &lt; 32 weeks of gestation age irrespective of their initial TSB values, nearly 100% ended up developing significant hyperbilirubinemia . Whereas in infants belonging to &gt; 32 weeks of gestation age ,a TSB level at 24 hours of life, was &lt; &lt;4.0 mg/dl in 4 newborns and none of them developed hyperbilirubinemia subsequently. In the remaining 86 newborns with TSB &ge;4</span><span lang=&quot;IT&quot; style=&quot;font&ndash;size:&#10;12.0pt;line&ndash;height:200%;mso&ndash;ansi&ndash;language:IT;font&ndash;weight:normal&quot;>.0 mg/dl, subsequent hyperbilirubinemia</span><span style=&quot;font&ndash;size:12.0pt;line&ndash;height:&#10;200%;font&ndash;weight:normal&quot;>, requiring phototherapy developed in 60 babies (69.8 %) {Sensitivity: 100 %, specificity: 13.3 %, positive predictive value 69.8%, negative predictive value 100% }<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%&quot;>Conclusion<o:p></o:p></span></p>
<p class=&quot;Default&quot; style=&quot;line&ndash;height:200%&quot;><span style=&quot;font&ndash;size:12.0pt;&#10;line&ndash;height:200%;font&ndash;weight:normal&quot;>Late Preterm babies with TSB levels higher than 4mg/dl at 24 hours of life have a significant risk of developing hyperbilirubinemia.<o:p></o:p></span></p></p>
			</abstract>			
			<counts>
				<ref-count count="7"/>
				<page-count count="2"/>
			</counts>
		</article-meta>
	</front>
</article>